...the PDE4 inhibitor in 2H21. Prothena gains on plans for Phase III AL amyloidosis studyShares of Prothena Corp. plc...

...Scripps Research Institute Orphan Technologies Ltd. Genmab A/S Johnson & Johnson Prothena Corp. plc Valneva...

...showed signs of efficacy and that it will continue to evaluate next steps. Roche’s partner Prothena Corp. plc...

...created position. He was SVP and general counsel at Insulet Corp. (NASDAQ:PODD). Neurological disorder play Prothena Corp. plc...
...and Robin Sawka, BioCentury Staff Ultragenyx Pharmaceutical Inc. Axsome Therapeutics Inc. ElevateBio LLC Satsuma Pharmaceuticals Inc. WindMIL Therapeutics Inc. Anika Therapeutics Inc. Prothena Corp. plc MacroGenics...

...Inc. (NASDAQ:PTCT). Its Phase II Parkinson’s disease and Alzheimer’s disease programs came through partnerships with Prothena Corp. plc...

...NYSE:NVS; SIX:NOVN). The company also hired David McNinch as CBO. He was formerly CCO at Prothena Corp. plc...

...Repatha Claims” ). EcoR1 acquires Woodford’s stake in Prothena EcoR1 Capital acquired the stake in Prothena Corp. plc...
...a series of troubles that have followed a long period of its flagship fund’s underperformance. Prothena...
...of a 23.6% stake in an SEC filing, but the seller’s identity was not revealed. Prothena...

...EcoR1 takes stake in Prothena Prothena Corp. plc (NASDAQ:PRTA) jumped $1.87 (27%) to $8.93 Tuesday after it disclosed...
...Fund, Tullis-Dickerson Capital Focus, Hunt Holdings and H.I.G. Elizabeth S. Eaton, Staff Writer Exagen Diagnostics Inc. Pharmaron Holding Ltd. Prothena Corp. plc EcoR1...

...a potential survival benefit in a subgroup of patients at highest risk for early mortality. Prothena Corp. plc...
...vs. placebo among 77 AL amyloidosis patients categorized as Mayo Stage IV. In April 2018, Prothena...
...trial for the indication, and an IDMC recommended discontinuing VITAL following a futility analysis (see "Prothena...

...of Europe, a newly created position. He was VP, head of European commercial operations at Prothena Corp. plc...